Rising home prices and conservative borrowing have today's homeowners sitting on a record amount of potential cash. Today's mortgage holders saw their home equity increase by...Real Estateread more
Stocks have been grinding sideways, but technical analysts say once they breakout, the move to the upside could be powerful.Market Insiderread more
Shareholders are accusing Tesla of improperly valuing the SolarCity deal, providing flawed analysis and misleading investors, among other things. Their allegations were...Technologyread more
Stocks were barely changed. American Express gained, but Netflix was a notable laggard.Marketsread more
The probe by the U.S. attorney's office of the Northern District of California is in its early stages, the Journal reported, citing people familiar with the matter.Health and Scienceread more
The fresh round of cuts is on top of an estimated 4,500 temporary layoffs GM and its suppliers handed out to employees as of Friday.Autosread more
Here are the most important things to know about Tuesday before you hit the door including earnings from Nike and likely updates on Trump's trade deals.Marketsread more
The Mac Pro is the only major Apple computer to be assembled in the United States. Most of Apple's products, including the iPhone, are assembled in China and are facing tariff...Technologyread more
Think about the last TV show you recommended to a friend, or the last one that was recommended to you. Odds are, it was from a premium service like HBO, Netflix or Amazon.Entertainmentread more
SpaceX is deep into development of its Starship rocket, with recent updates from CEO Elon Musk showing the first one under construction.Investing in Spaceread more
The new wireless earbuds, codenamed "Puget," are expected to come with an accelerometer and be able to monitor things like the distance run, calories burned, and pace of...Technologyread more
* Dassault Systemes' biggest ever takeover
* Offering $92.25/share to buy Medidata
* Medidata strong in life sciences field
* Deal to boost earnings from 2020 onwards (Adds comments from fund manager and broker)
PARIS, June 12 (Reuters) - France's Dassault Systemes moved to build up its life sciences presence with a $5.8 billion cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials.
Dassault Systemes has been doing deals to diversify its technology and software businesses further and its agreed acquisition of Medidata, its largest, follows its purchases of companies including Trace Software and Argosim.
Medidata has a market capitalisation of around $5.9 billion, Refinitiv Eikon data shows, while Dassault has a stock market value of around 36 billion euros ($41 billion).
Although the $92.25 per share offered marked a slight discount to Medidata's closing price of $94.75 on June 11, analysts said that it was at a premium of 6.6% to Medidata's 50-day average price of $86.50 over the last 50 days.
Medidata's shares had also risen 5.5% to around $100 in after-hours trading on Tuesday, on growing speculation of a takeover by Dassault Systemes.
The French company added the Medidata takeover, which it said has a $5.8 billion enterprise value, would strengthen its position in life sciences and boost earnings from 2020 onwards.
"Multidiscipline scientific innovation and industrial performance call for a platform approach connecting the dots between people, ideas and data," said Bernard CharlEes, Vice Chairman and CEO of Dassault SystEemes.
Deloitte this year forecast strong growth in the life sciences industry, saying it would benefit from a general rise in spending on healthcare, which in turn would necessitate more spending on technology. (https://bit.ly/2evoaRZ)
France's Dassault family has stakes in both Dassault SystEemes and the aerospace-focused Dassault Aviation company, but the two are separate entities.
Dassault Systeme's finance director, Pascal Daloz, said the French company had also signed a debt financing deal worth around 4 billion euros to fund its purchase of Medidata.
Invest Securities said the size of the deal had taken some investors by surprise, but Roche Brune Asset Management fund manager Gregoire Laverne said it was seen as a positive step.
"Dassault Systemes nevertheless has a big enough balance sheet to able to finance part of the acquisition," said Laverne, whose firms owns Dassault shares.
Medidata had 2018 revenue of $636 million, and Dassault Systemes expects to close the deal in the fourth quarter. ($1 = 0.8825 euros) (Reporting by Sudip Kar-Gupta; Editing by Muralikumar Anantharaman, Gopakumar Warrier and Alexander Smith)